In addition, lnc-AROD can enhance hepatocellular carcinoma proliferation by interacting with serine- and arginine-rich splicing factor 3 (SRSF3) to trigger pyruvate kinase M (PKM) switching from PKM1 to PKM2 (23, –, 25). Here, SRSF3 is linked to hepatocellular carcinoma.